近期论文

查看导师新发文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Vardy, J., Dhillon, H., Pond, G., Rourke, S., Bekele, T., Renton, C., Dodd, A., Zhang, H., Beale, P., Clarke, S., et al (2015). Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study. Journal of Clinical Oncology, 33(34), 4085-4092. [More Information] Arzuman, L., Beale, P., Proschogo, N., Yu, J., Huq, F. (2015). Combination of genistein and cisplatin with two designed monofunctional platinum agents in human ovarian tumour models. Anticancer Research: international journal of cancer research and treatment, 35(11), 6027-6039. Moth, E., Parry, J., Stockler, M., Beale, P., Blinman, P., Della Fiorentina, S., Kiely, B. (2015). Doctor to doctor communication of prognosis in metastatic cancer: a review of letters from medical oncologists to referring doctors. Internal Medicine Journal, 45(9), 909-915. [More Information] Arzuman, L., Beale, P., Yu, J., Huq, F. (2015). Monofunctional platinum-containing pyridine-based ligand acts synergistically in combination with the phytochemicals curcumin and quercetin in human ovarian tumour models. Anticancer Research: international journal of cancer research and treatment, 35(5), 2783-2794. Oza, A., Cook, A., Pfisterer, J., Embleton, A., Ledermann, J., Pujade-Lauraine, E., Kristensen, G., Carey, M., Beale, P., Cervantes, A., et al (2015). Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. The Lancet Oncology, 16(8), 928-936. [More Information] Tan, C., Read, J., Phan, V., Beale, P., Peat, J., Clarke, S. (2015). The relationship between nutritional status, inflammatory markers and survival in patients with advanced cancer: a prospective cohort study. Supportive Care in Cancer, 23(2), 385-391. [More Information] Huq, F., Yu, J., Beale, P., Chan, C., Arzuman, L., Nessa, M., Mazumder, M. (2014). Combinations of Platinums and Selected Phytochemicals as a Means of Overcoming Resistance in Ovarian Cancer. Anticancer Research: international journal of cancer research and treatment, 34(1), 541-545. Oh, B., Butow, P., Boyle, F., Beale, P., Costa, D., Pavlakis, N., Bell, D., Davis, E., Choi, S., Lee, M., Clarke, S., et al (2014). Effects of Qigong on Quality of Life, Fatigue, Stress, Neuropathy, and Sexual Function in Women with Metastatic Breast Cancer: A Feasibility Study. International Journal of Physical Medicine & Rehabilitation, 2(4), 1-6. [More Information] Wu, J., Ludlow, J., De Vries, B., Black, K., Beale, P. (2014). Single-dose methotrexate treatment for ectopic pregnancy and pregnancy of unknown location and progesterone as a predictor of success. Australian and New Zealand Journal of Obstetrics and Gynaecology, 54(5), 469-474. [More Information] Arzuman, L., Beale, P., Chan, C., Yu, J., Huq, F. (2014). Synergism from Combinations of tris(benzimidazole) monochloroplatinum(II) Chloride with Capsaicin, Quercetin, Curcumin and Cisplatin in Human Ovarian Cancer Cell Lines. Anticancer Research: international journal of cancer research and treatment, 34(10), 5453-5464. Hamad, S., Beale, P., Yu, J., Huq, F. (2014). Synthesis and activity of three new trinuclear platinums with cis-geometry for terminal metal centres. Journal of Biomedical Science, 21(1), 1-12. [More Information] Hamad, S., Beale, P., Yu, J., Huq, F. (2014). Synthesis and Antitumour Activity of a New Trinuclear Platinum Compound [{cis-PtCI(NH3)2u {trans-Pt(3-hydroxypyridine)2H2N(CH2)5NH2)2}] CI4 in Human Ovarian Cancer Cells. Anticancer Research: international journal of cancer research and treatment, 34(4), 1923-1929. Arzuman, L., Beale, P., Yu, J., Proschogo, N., Huq, F. (2014). Synthesis of a monofunctional platinum compound and its activity alone and in combination with phytochemicals in ovarian tumor models. Anticancer Research: international journal of cancer research and treatment, 34(12), 7077-7090. Al-Eisawi, Z., Beale, P., Chan, C., Yu, J., Huq, F. (2013). Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumor models. Journal of Ovarian Research, 6(Nov 2013), 1-11. [More Information] Vardy, J., Dhillon, H., Clarke, S., Olesen, I., Leslie, F., Warby, A., Beith, J., Sullivan, A., Hamilton, A., Beale, P., Rittau, A., McLachlan, A. (2013). Investigation of herb-drug interactions with ginkgo biloba in women receiving hormonal treatment for early breast cancer. SpringerPlus, 2(1), 1-5. [More Information] Stark, D., Nankivell, M., Pujade-Lauraine, E., Kristensen, G., Elit, L., Stockler, M., Hilpert, F., Cervantes, A., Brown, J., Lanceley, A., et al (2013). Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial. Lancet Oncology, 14(3), 236-243. [More Information] Deqnah, N., Yu, J., Beale, P., Fisher, K., Huq, F. (2013). Synthesis of trans-(4-hydroxypyridine)(ammine)dichloroplatinum(II) and its activity in the human ovarian tumour models. Medicinal Chemistry, 9(4), 539-544. [More Information] Lim, S., Wilson, S., Hunter, A., Jane, H., Beale, P. (2013). Takotsubo Cardiomyopathy and 5-Fluorouracil: Getting to the Heart of the Matter. Case Reports in Oncological Medicine, 2013, 206765. [More Information] Kiely, B., Martin, A., Tattersall, M., Nowak, A., Goldstein, D., Wilcken, N., Wyld, D., Abdi, E., Glasgow, A., Beale, P., Stockler, M., et al (2013). The Median Informs the Message: Accuracy of Individualized Scenarios for Survival Time Based on Oncologists' Estimates. Journal of Clinical Oncology, 31(28), 3565-3571. [More Information] Kiely, B., McCaughan, G., Christodoulou, S., Beale, P., Grimison, P., Trotman, J., Tattersall, M., Stockler, M. (2013). Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience. Supportive Care in Cancer, 21(2), 369-376. [More Information]